Basal–bolus insulin versus sliding‐scale insulin for inpatient glycaemic control: a clinical practice comparison

Abstract

Under routine clinical conditions, BBI is effective and safe across a range of patients and appears to be superior to SSI. Clinical improvements reflected those seen in a strict formal study setting.